🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#Heartfailure expert and PI for Corvia's RESPONDER-HF trial, Sheldon Litwin from Medical University of South Carolina (MUSC) describes the unmet need of #HFpEF and how #atrialshunt therapy, being evaluated through #RESPONDERHF, could be a game-changer for patients & clinicians. #clinicaltrials #CardioTwitter

In “BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction”, Sanjiv J. Shah, MD shares imperfections in using NPs in #HFpEF. Corvia's #RESPONDERHF #atrialshunt trial includes these HFpEF pts with low NPs who might otherwise be overlooked. doi.org/10.1093/eurhea…

Congratulations to Vikrant Jagadeesan, MD and the team at @WVUMedicine for leading the way and being the first center in West Virginia to enroll a patient in the #RESPONDERHF trial. Together, we are working to give #heartfailure patients another reason to hope. #HFpEF #atrialshunt

#Heartlive in Munich begins later this week! Hear from the experts - Profs. Ulf Landmesser, Martin Bergmann, and Mirjam Keßler - at our symposium on #atrialshunt therapy for #HFpEF. Stop by booth #13 and learn about our confirmatory trial #RESPONDERHF. #Corvia #heartfailure

We hope to see you in Wiesbaden, Germany at #CSIFocusDHF! Thanks in advance to Prof. Rudin Pistulli who will present his experience with the #Corvia Atrial Shunt and to CSI Congress for its continued focus on the potential of #atrialshunt therapy for #heartfailure. #CSIDHF

As the year comes to a close, we want to take a moment to express our #gratitude to our investigators, customers, and partners for their support throughout the year. May this #holidayseason bring you love, light, and laughter, and the New Year bring much #prosperity & #success.

February is American #HeartMonth ❤️, a time to raise awareness about heart health and cardiovascular disease. #CorviaMedical is proud to be part of the solution to improve the lives of millions of people who suffer from heart disease. #HeartMonth2024 #cardiotwitter #corvia

FACT: #HeartFailure affects 6.2 million people in the US—this may include someone you love. Join #Corvia this #HeartMonth to prioritize #hearthealth awareness. Your knowledge could change a life. Learn more about heart failure here: bit.ly/3SsnXjO #twittercardio

Congratulations to vijay mathur and the Arizona Heart Rhythm Center team for the great coverage of their REDUCE LAP-HF II patient and their ongoing work to bring #atrialshunt therapy to #heartfailure patients in AZ. fox10phoenix.com/video/1416675 #HFpEF #CardioTwitter #clinicaltrials #RESPONDERHF

It's the last day of #ACC24, but there's still time time to come learn about #atrialshunt therapy and which #HFpEF patients might from participating in the #RESPONDERHF trial. Come see us at booth 3338! #CardioTwitter #HeartFailure

We continue to learn which #heartfailure patients may benefit most from #atrialshunt therapy. Recent RELIEVE-HF data reinforces the importance of patient selection and suggests we are on the right path with #RESPONDERHF to confirm optimal #HFpEF patients. us.corviamedical.com/corvias-respon…

Corvia Highlights Importance of Patient Selection in RESPONDER-HF Atrial Shunt Trial | Corvia Medical, Inc. citoday.com/news/corvia-hi…

Happy #NationalNursesDay to all the dedicated heart failure nurses! Your unwavering commitment & compassion make a significant impact on the lives of #heartfailure patients. Your dedication makes all the difference. #NursesMakeTheDifference #GratefulHeart #NursesWeek2024 #Corvia

During #NationalNursesWeek, we extend our deepest appreciation to all the incredible #HeartFailure nurses. Your expertise, empathy, and dedication are instrumental in improving life for millions. Thank you for being the heartbeat of compassionate care. #NursesWeek2024 #Corvia

What is the long-term effect of an #atrialshunt? Recently published data in JAMA Cardiology by Ravi Patel shows favorable effects of the Corvia Atrial Shunt on cardiac structure & function in #heartfailure patients. #HFpEF #cardiotwitter jamanetwork.com/journals/jamac…

Great interview with Sanjiv J. Shah, MD regarding the favorable long-term effects of an #atrialshunt observed in REDUCE LAP-HF II #heartfailure patients.

Jimmy's story gives us confidence we are on the right path with our confirmatory trial #RESPONDERHF. Learn more at treatmyheartfailure.com. Sheldon Litwin #HFpEF #atrialshunt Caution: Investigational device, limited by US law to investigational use. postandcourier.com/health/musc-he…

#CSIFrankfurt2024 is almost here! Don't miss Wednesday's #Interatrialshunt Workshop where Amin Polzin from Uniklinik Düsseldorf will share lessons learned from REDUCE LAP-HF II & how these findings are being validated in #RESPONDERHF. #atrialshunt #HFpEF #cardiotwitter #heartfailure

#CSIFrankfurt2024 is here! Don't miss today's session on #Interatrialshunt therapy at 16:15 CEST. With two #atrialshunt randomized trials now complete, come hear Amin Polzin discuss why the #Corvia Atrial Shunt holds promise for #HFpEF patients! #cardiotwitter #structuralheart

Corvia is proud to support the Medical University of South Carolina (MUSC) #charlestonHFpEF Conference from July 19-21. Heart failure with preserved ejection fraction (#HFpEF) is a hot topic — join course director Sheldon Litwin & other esteemed faculty to discover why! #heartfailure #atrialshunt #cardiotwitter